Category 5 - DIAGNOSTIC IMAGING SERVICES
61369 - Additional Information
Item Start Date:
01-Nov-1999
Description Updated:
01-May-2020
Schedule Fee Updated:
01-Nov-2006
Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET
Indium-labelled octreotide study (including single photon emission tomography when undertaken), if:
(a) a gastro-entero-pancreatic endocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or
(b) both:
(i) a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified on the basis of conventional techniques; and
(ii) the study is to exclude additional disease sites (R)
Fee: $2,015.75 Benefit: 75% = $1,511.85 85% = $1,917.05
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change